The Biotech Growth Trust PLC (LON:BIOG - Get Free Report) crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 898.04 ($11.07) and traded as low as GBX 832 ($10.26). The Biotech Growth Trust shares last traded at GBX 832 ($10.26), with a volume of 27,991 shares trading hands.
The Biotech Growth Trust Trading Up 1.7 %
The company has a debt-to-equity ratio of 13.03, a current ratio of 0.33 and a quick ratio of 0.00. The business's 50-day moving average price is GBX 898.04 and its two-hundred day moving average price is GBX 977.63. The company has a market capitalization of £271.82 million, a price-to-earnings ratio of 408.70 and a beta of 0.50.
The Biotech Growth Trust (LON:BIOG - Get Free Report) last announced its quarterly earnings data on Wednesday, November 27th. The company reported GBX 0.20 ($0.00) EPS for the quarter. The Biotech Growth Trust had a net margin of 92.85% and a return on equity of 21.57%.
Insider Transactions at The Biotech Growth Trust
In other news, insider Julie Tankard acquired 1,022 shares of the firm's stock in a transaction on Wednesday, December 4th. The stock was purchased at an average price of GBX 972 ($11.99) per share, for a total transaction of £9,933.84 ($12,248.88). Also, insider Hamish Baillie bought 3,000 shares of The Biotech Growth Trust stock in a transaction dated Wednesday, November 27th. The shares were bought at an average cost of GBX 931 ($11.48) per share, with a total value of £27,930 ($34,438.96). Over the last ninety days, insiders purchased 6,222 shares of company stock worth $5,659,584. Corporate insiders own 0.71% of the company's stock.
The Biotech Growth Trust Company Profile
(
Get Free Report)
The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).
Recommended Stories
Before you consider The Biotech Growth Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Biotech Growth Trust wasn't on the list.
While The Biotech Growth Trust currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
